BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 28, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2003
View Archived Issues
Gastrointestinal safety of AZD-3582 demonstrated in humans
Read More
Efficacy and tolerance of MS-275 in patients with refractory tumors
Read More
Etanercept monotherapy for plaque psoriasis
Read More
Ximelagatran demonstrates efficacy in VTE
Read More
Beneficial effects of UCB-34714 in neuropathy and epilepsy
Read More
Antitumor effects of TZT-1027 in advanced cancer patients
Read More
Vernalis updates development status of key R&D programs
Read More
R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Lorantis
Read More
Organon and CARIM join forces in atherosclerosis research
Read More
Wex updates Tectin progress
Read More
Novel MAO-B inhibitors and their use patented by Roche
Read More
New muscarinic antagonists identified at Schering
Read More
Aventis describes new series of Th2 cell modulators
Read More
New JNK3 inhibitors with potential utility in cerebral ischemia and other CNS disorders
Read More
Novel antibacterial agents covered by Bayer patent
Read More
Enanta team presents new semisynthetic macrolide antibiotics
Read More
NGF-modulating compound in development at Krenitsky for neurodegenerative conditions
Read More
Enrollment completed in phase IIa BPH study of BXL-628
Read More
BresaGen spin-off to create leading stem cell therapy company
Read More
Gadovist 1.0 receives E.U. approval for MRA
Read More
R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Opexa Pharmaceuticals
Read More
Solvay describes preclinical studies with centrally available NK1 receptor antagonist SLV-323
Read More
ER-022604: a neurotrophic factor-like compound with potential in motoneuronal diseases
Read More
Inhibition of GSK-3beta reduces neuronal death in culture and in animal model
Read More
